Trademark: 97777942
Word
CX
Status Date
Tuesday, June 18, 2024
Registration Number
7417642
Registration Date
Tuesday, June 18, 2024
Filing Date
Thursday, February 2, 2023
Published for Opposition
Tuesday, April 2, 2024
42 Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy
The mark consists of a stylized image of an "X" connected by lines and dots to a letter "C" to form the lettering "CX".
Color is not claimed as a feature of the mark.
Nov 13, 2023
Non-Final Action E-Mailed
Feb 7, 2023
New Application Entered
Feb 21, 2023
New Application Office Supplied Data Entered
Oct 31, 2023
Assigned To Examiner
Nov 13, 2023
Non-Final Action Written
Nov 13, 2023
Notification Of Non-Final Action E-Mailed
Feb 6, 2024
Teas Response To Office Action Received
Feb 6, 2024
Correspondence Received In Law Office
Feb 7, 2024
Teas/Email Correspondence Entered
Feb 26, 2024
Approved For Pub - Principal Register
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Apr 2, 2024
Published For Opposition
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 13, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 13, 2024
Teas Change Of Correspondence Received
Jun 18, 2024
Registered-Principal Register
Jun 18, 2024
Notice Of Registration Confirmation Emailed
Jun 13, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Trademark Alertz updated from USPTO on 2030-01-24
